BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer

NCT01679405 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped No sufficient clinical or molecular signals for efficacy were observed.

Conditions

Metastatic Disease

Interventions

DRUG: BIBW 2992

Sponsor

Johannes Gutenberg University Mainz